glympse bio logo

What if you could get a glimpse inside the body? Glympse Bio is developing a powerful new paradigm in noninvasive disease monitoring to improve human health.

The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platform technology was originally developed at MIT by world-renowned nanomedicine and biomedical engineering experts Sangeeta Bhatia and Gabe Kwong. The technology platform has been published multiple times in prestigious journals such as Nature Biotechnology and the Proceedings of the National Academy of Sciences.

Kwong et al., Nat Biotechnol. 2013 Jan; 31(1):63-70
Kwong et al., Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12627-32

For more information, contact:

c/o LabCentral, 700 Main Street – North, Cambridge, MA 02139